Gyre Therapeutics (GYRE) Current Leases: 2019-2025
Historic Current Leases for Gyre Therapeutics (GYRE) over the last 6 years, with Sep 2025 value amounting to $626,000.
- Gyre Therapeutics' Current Leases fell 9.80% to $626,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $626,000, marking a year-over-year decrease of 9.80%. This contributed to the annual value of $713,000 for FY2024, which is 239.52% up from last year.
- According to the latest figures from Q3 2025, Gyre Therapeutics' Current Leases is $626,000, which was up 0.64% from $622,000 recorded in Q2 2025.
- Over the past 5 years, Gyre Therapeutics' Current Leases peaked at $2.0 million during Q4 2021, and registered a low of $100,000 during Q1 2024.
- Over the past 3 years, Gyre Therapeutics' median Current Leases value was $642,500 (recorded in 2024), while the average stood at $553,625.
- In the last 5 years, Gyre Therapeutics' Current Leases tumbled by 79.34% in 2022 and then soared by 705.00% in 2025.
- Gyre Therapeutics' Current Leases (Quarterly) stood at $2.0 million in 2021, then crashed by 75.11% to $492,000 in 2022, then plummeted by 57.32% to $210,000 in 2023, then soared by 239.52% to $713,000 in 2024, then fell by 9.80% to $626,000 in 2025.
- Its Current Leases was $626,000 in Q3 2025, compared to $622,000 in Q2 2025 and $805,000 in Q1 2025.